gracecast-096_lung-cancer_mm in lc pt 1: dr. charles rudin on the lung cancer mutation consortium
Published 12 years ago • 105 plays • Length 17:36Download video MP4
Download video MP3
Similar videos
-
8:06
gracecast-145_lung_highlights in lung cancer, 2013: squamous cell nsclc and antipd1
-
13:44
gracecast-079_lung-cancer_challenging cases in lung cancer: unresectable locally advanced nsclc
-
10:49
gracecast-097_lung-cancer_mm in lc pt 2: dr. alice shaw on mutation patterns by patient features
-
6:56
gracecast - leading treatment options for patients with negative tumor pd-l1 nsclc with dr. stephen
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
10:06
gracecast-019_lung-cancer_cancer lifeline lecture part 1 sclc
-
4:10
overcoming resistance in alk or kras nsclc - lung cancer onctalk 2022
-
25:07
gracecast-101_lung-cancer_mm in lc pt6: dr. goss on incorporating markers across a hc system
-
44:55
lung cancer | dr. grace dy | clinical oncology year in review
-
19:57
gracecast-015_cancer-101_david djang interview on pet scans
-
12:12
single or dual agent io/chemotherapy for pd-l1 negative nsclc
-
5:11
gracecast-114_lung-cancer_asco 2012 lc highlights: dr. neal on mek inhibitor selumetinib in nsclc
-
17:28
gracecast-098_lung-cancer_mm in lc pt 3: who to test and what to test for -- panel discussion
-
24:30
gracecast-100_lung-cancer_mm in lc pt 5: dr. spigel on incorporating targets into clinical trials
-
3:22
discussing biomarkers and pd-l1 testing with your doctor - lung cancer onctalk 2022
-
3:43
gracecast-146_lung_highlights in lung cancer, 2013: maintenance therapy in advanced nsclc
-
10:37
gracecast-141_lung_highlights in lung cancer, 2012: alk inhibitors for patients with alk or ros1
-
17:24
gracecast-119_lung-cancer_managing pulmonary complications of lc treatment: chemo-induced damage
-
40:09
gracecast-076_lung-cancer_asco 2011 highlights - sclc, early stage nsclc and mesothelioma
-
10:03
gracecast-011_lung-cancer_second line treatment for nsclc
-
14:52
gracecast-031_lung-cancer_treatment - past, present, and future
-
9:19
gracecast-004_lung-cancer_antiangiogenesis in first line nsclc